Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Kaneko

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 3, 2016
Physiological Roles of Ubiquitin Ligases Related to the Endoplasmic ReticulumMasayuki Kaneko
The Annals of Pharmacotherapy|April 30, 2021
Effect of PARP Inhibitors as Maintenance Treatment on Restricted Mean Survival Time in Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review and Meta-analysisMasayuki Kaneko
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 5, 2012
[Molecular pharmacological studies on the protection mechanism against endoplasmic reticulum stress-induced neurodegenerative disease]Masayuki Kaneko
The Annals of Pharmacotherapy|February 10, 2018
Assessment of Cardiovascular Risk With Glucagon-Like Peptide 1 Receptor Agonists in Patients With Type 2 Diabetes Using an Alternative Measure to the Hazard RatioMasayuki Kaneko, Mamoru Narukawa
Clinical Drug Investigation|March 20, 2019
Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes MellitusMasayuki Kaneko, Mamoru Narukawa
Diabetes Research and Clinical Practice|June 21, 2016
Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitusMasayuki Kaneko, Mamoru Narukawa
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 2, 2004
[Protective effects of HRD1 and 4-phenylbutyric acid against neuronal cell death]Masayuki Kaneko, Yasuyuki Nomura
Life Sciences|November 11, 2003
ER signaling in unfolded protein responseMasayuki Kaneko, Yasuyuki Nomura
Clinical Drug Investigation|December 4, 2018
Effects of Sodium-glucose Cotransporter 2 Inhibitors on Amputation, Bone Fracture, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Using an Alternative Measure to the Hazard RatioMasayuki Kaneko, Mamoru Narukawa
The Annals of Pharmacotherapy|June 18, 2017
Assessment of the Risk of Hospitalization for Heart Failure With Dipeptidyl Peptidase-4 Inhibitors, Saxagliptin, Alogliptin, and Sitagliptin in Patients With Type 2 Diabetes, Using an Alternative Measure to the Hazard RatioMasayuki Kaneko, Mamoru Narukawa
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 3, 2016
Physiological Roles of Ubiquitin Ligases Related to the Endoplasmic ReticulumMasayuki Kaneko
The Annals of Pharmacotherapy|April 30, 2021
Effect of PARP Inhibitors as Maintenance Treatment on Restricted Mean Survival Time in Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review and Meta-analysisMasayuki Kaneko
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 5, 2012
[Molecular pharmacological studies on the protection mechanism against endoplasmic reticulum stress-induced neurodegenerative disease]Masayuki Kaneko
The Annals of Pharmacotherapy|February 10, 2018
Assessment of Cardiovascular Risk With Glucagon-Like Peptide 1 Receptor Agonists in Patients With Type 2 Diabetes Using an Alternative Measure to the Hazard RatioMasayuki Kaneko, Mamoru Narukawa
Clinical Drug Investigation|March 20, 2019
Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes MellitusMasayuki Kaneko, Mamoru Narukawa
Diabetes Research and Clinical Practice|June 21, 2016
Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitusMasayuki Kaneko, Mamoru Narukawa
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 2, 2004
[Protective effects of HRD1 and 4-phenylbutyric acid against neuronal cell death]Masayuki Kaneko, Yasuyuki Nomura
Life Sciences|November 11, 2003
ER signaling in unfolded protein responseMasayuki Kaneko, Yasuyuki Nomura
Clinical Drug Investigation|December 4, 2018
Effects of Sodium-glucose Cotransporter 2 Inhibitors on Amputation, Bone Fracture, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Using an Alternative Measure to the Hazard RatioMasayuki Kaneko, Mamoru Narukawa
The Annals of Pharmacotherapy|June 18, 2017
Assessment of the Risk of Hospitalization for Heart Failure With Dipeptidyl Peptidase-4 Inhibitors, Saxagliptin, Alogliptin, and Sitagliptin in Patients With Type 2 Diabetes, Using an Alternative Measure to the Hazard RatioMasayuki Kaneko, Mamoru Narukawa
Pageof 13